Drugs / Clomiphene
last change 3 days ago re-read 2 minutes ago

Clomiphene

Other / unclassified targets ESR1

Developed for
polycystic ovary syndrome · infertility disorder · anovulation · female infertility · male infertility · hypogonadism, male · hypogonadotropic hypogonadism · ovarian dysfunction
+15 more · ovarian hyperstimulation syndrome · pregnancy disorder · spermatogenic failure · acromegaly · hyperprolactinemia · hypogonadism · menstrual disorder · prolactin-producing pituitary gland adenoma · rotator cuff syndrome · substance-related disorder · azoospermia · endometriosis · female reproductive system disorder · obesity disorder · ovarian disorder
Investigated by
Ain Shams University · Mansoura University · Ain Shams Maternity Hospital · Assiut University · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · National Center for Research Resources (NCRR)
+70 more · Rachel Mejia · University Magna Graecia · University of Illinois at Chicago · University of Sao Paulo · University of Virginia · Weill Medical College of Cornell University · Yazd Research & Clinical Center for Infertility · Ahmed Fathy Ali Mohamed Ghanem · Al-Thawra Modern General Hospital · Albany Medical College · American Diabetes Association · American Society for Reproductive Medicine · American University of Beirut Medical Center · Auckland Medical Research Foundation · Beijing Fengtai Hospital of Integrated Traditional and Western Medicine · Beijing First Hospital of integrated Chinese and Western Medicine · Beijing Hospital of Traditional Chinese Medicine · Beijing Obstetrics and Gynecology Hospital · Benha University · Bioroma · Dongzhimen Hospital, Beijing · Eugin · Federal University of São Paulo · Felipe Henning Gaia Duarte · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Fundacion Dexeus · HITEC-Institute of Medical Sciences · Hospices Civils de Lyon · IRCCS San Raffaele · Ibn Sina Hospital · Istituti Clinici Zucchi · Istituto Clinico Humanitas · Johns Hopkins University · Kufa University · Laboratory Corporation of America · Laylay Mohammed Khalleefah Alhibshi · Mansoura Integrated Fertility Center · Mayo Clinic · Menoufia Obstetrics and Gynecology Group · Mercia Barnes Trust of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists · Milton S. Hershey Medical Center · Navy General Hospital, Beijing · Nova Clinic, Russia · Partnership for Clean Competition · RenJi Hospital · Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) · Royan Institute · Sana'a University · Semnan University of Medical Sciences · Shaare Zedek Medical Center · Shakeela Ishrat · ShangHai Ji Ai Genetics & IVF Institute · Sheba Medical Center · Society for Reproductive Investigation · Sports Medicine Research and Testing Laboratory · State University of New York at Buffalo · Stuart Willick · Szeged University · The Egyptian IVF-ET Center · The University of Hong Kong · University Hospitals Cleveland Medical Center · University of Auckland, New Zealand · University of Chicago · University of Oklahoma · University of Southern California · University of Utah · University of Wisconsin, Madison · Xiyuan Hospital of China Academy of Chinese Medical Sciences · Yale University · Yazd Medical University

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) CLOMID 1967-02-01 fda.gov

Trials 65 · started per year

today
US approved 1967
1
2
1
2
1
1
1
1
3
3
4
2
2
2
4
9
2
4
3
4
2
2
2
3
2
1
1
196619671968196919701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT04361175 Mar → Sep 2021 infertility disorder Assiut University Unknown No outcome recorded
Phase 16 trials
Phase 1 NCT06813118 Jun 2024 → Mar 2025 polycystic ovary syndrome HITEC-Institute of Medical Sciences Completed No outcome recorded
Phase 1 NCT04177693 Nov 2020 → Jan 2022 leiomyoma Yale University Completed No outcome recorded
Phase 1 NCT03028532 Mar 2017 → Jan 2018 substance abuse Stuart Willick Completed No outcome recorded
Phase 1 NCT02448459 May 2015 → Mar 2016 infertility disorder University of Sao Paulo Completed No outcome recorded
Phase 1 NCT02024984 Nov 2013 → Jun 2014 polycystic ovary syndrome Ain Shams Maternity Hospital Unknown No outcome recorded
Phase 1 NCT01289756 Dec 2009 → Nov 2014 anovulation Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) Completed No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT01340521 Mar 1991 → Mar 1994 infertility disorder Milton S. Hershey Medical Center Completed No outcome recorded
Phase 29 trials
Phase 2 NCT04944836 Mar 2023 → Jul 2028 expected rotator cuff syndrome University of Utah Recruiting No outcome recorded
Phase 2 NCT05096169 May 2022 → Jan 2025 hypogonadism Weill Medical College of Cornell University Withdrawn No outcome recorded
Phase 2 NCT03709849 Feb 2019 → Mar 2020 anovulation, hyperprolactinemia, menstrual disorder, ovarian dysfunction +1 Xiyuan Hospital of China Academy of Chinese Medical Sciences Unknown No outcome recorded
Phase 2 NCT02523898 Nov 2015 → Apr 2022 polycystic ovary syndrome Semnan University of Medical Sciences Terminated No outcome recorded
Phase 2 NCT03933618 Apr 2015 → Mar 2017 hypogonadism, male Albany Medical College Completed No outcome recorded
Phase 2 NCT01880086 Aug 2013 → Mar 2016 hypogonadism, male, male infertility, substance-related disorder Weill Medical College of Cornell University Completed No outcome recorded
Phase 2 NCT02274311 Jan 2011 → Oct 2014 acromegaly Felipe Henning Gaia Duarte Completed No outcome recorded
Phase 2 NCT01155518 Jun 2010 → Dec 2013 hypogonadotropic hypogonadism, type 2 diabetes mellitus State University of New York at Buffalo Terminated No outcome recorded
Phase 2 NCT00697814 Jun 2004 → Jun 2005 hypogonadotropic hypogonadism, prolactin-producing pituitary gland adenoma Federal University of São Paulo Completed No outcome recorded
Phase 2/32 trials
Phase 2/3 NCT03549741 Jul 2018 → Jun 2019 infertility disorder Assiut University Unknown No outcome recorded
Phase 2/3 NCT03770026 Jan 2018 → Jan 2019 anovulation Benha University Completed No outcome recorded
Phase 37 trials
Phase 3 NCT03615547 Jan 2026 → Jan 2029 spermatogenic failure Hospices Civils de Lyon Withdrawn No outcome recorded
Phase 3 NCT07616973 May 2023 → May 2026 overdue female infertility Sana'a University Active not recruiting No outcome recorded
Phase 3 NCT06564961 Jul 2022 → Jun 2023 spermatogenic failure Shakeela Ishrat Completed No outcome recorded
Phase 3 NCT02255578 Sep 2014 → Sep 2017 polycystic ovary syndrome Sheba Medical Center Unknown No outcome recorded
Phase 3 NCT02732808 Sep 2014 → Apr 2016 female infertility Royan Institute Completed No outcome recorded
Phase 3 NCT01008319 Oct 2009 → Nov 2015 anovulation, ovarian dysfunction University of Oklahoma Completed No outcome recorded
Phase 3 NCT00068861 Nov 2002 → Feb 2006 female infertility, polycystic ovary syndrome, pregnancy disorder Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Completed No outcome recorded
Phase 420 trials
Phase 4 NCT06701071 Jun 2025 → Jun 2028 expected female infertility University of Southern California Recruiting No outcome recorded
Phase 4 NCT07523022 Sep 2024 → Sep 2026 expected male infertility Szeged University Enrolling by invitation No outcome recorded
Phase 4 NCT04157725 Jun 2023 → Jan 2025 infertility disorder, polycystic ovary syndrome American University of Beirut Medical Center Unknown No outcome recorded
Phase 4 NCT04983173 Nov 2021 → Mar 2026 infertility disorder Fundacion Dexeus Completed No outcome recorded
Phase 4 NCT05206448 Oct 2020 → Apr 2024 overdue infertility disorder, polycystic ovary syndrome Rachel Mejia Active not recruiting No outcome recorded
Phase 4 NCT03989024 Jul 2019 → Dec 2020 anovulation, infertility disorder, polycystic ovary syndrome RenJi Hospital Unknown No outcome recorded
Phase 4 NCT03400722 Dec 2017 → Aug 2018 female infertility, ovarian hyperstimulation syndrome Nova Clinic, Russia Unknown No outcome recorded
Phase 4 NCT03309436 Aug 2017 → Jun 2018 female infertility ShangHai Ji Ai Genetics & IVF Institute Unknown No outcome recorded
Phase 4 NCT02802865 Aug 2016 → May 2018 infertility disorder, polycystic ovary syndrome Rachel Mejia Completed No outcome recorded
Phase 4 NCT02479256 Jun 2015 → May 2016 polycystic ovary syndrome Ain Shams University Completed No outcome recorded
Phase not applicable19 trials
NCT04052607 Sep 2019 → Apr 2020 infertility disorder Ibn Sina Hospital Terminated No outcome recorded
NCT04619914 Mar → Jul 2019 Laylay Mohammed Khalleefah Alhibshi Completed No outcome recorded
NCT03316469 Jul → Oct 2018 polycystic ovary syndrome Ain Shams University Unknown No outcome recorded
NCT03178500 Feb 2017 → Jul 2018 polycystic ovary syndrome Ain Shams Maternity Hospital Unknown No outcome recorded
NCT02775877 May 2016 → Jun 2019 female infertility Navy General Hospital, Beijing Unknown No outcome recorded
NCT02647424 Dec 2015 → Dec 2017 infertility disorder, polycystic ovary syndrome The University of Hong Kong Unknown No outcome recorded
NCT02377479 Mar 2015 → Mar 2017 infertility disorder University Hospitals Cleveland Medical Center Withdrawn No outcome recorded
NCT01718444 Mar 2015 → Jun 2016 infertility disorder, polycystic ovary syndrome University of Illinois at Chicago Terminated No outcome recorded
NCT02544776 Jan → Aug 2015 anovulation Ahmed Fathy Ali Mohamed Ghanem Completed No outcome recorded
NCT02269306 Jan 2011 → Jan 2013 anovulation Menoufia Obstetrics and Gynecology Group Completed No outcome recorded
Also used as a comparator or background therapy in 88 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 03 trials
Phase 0 NCT03681197 Comparator Jun 2018 → Apr 2019 infertility disorder Elham Raafat Unknown No outcome recorded
Phase 0 NCT03566225 Comparator Jan 2018 → Feb 2021 Ain Shams University Completed No outcome recorded
Phase 0 NCT01909141 Comparator Aug 2013 → Feb 2014 infertility disorder, polycystic ovary syndrome Cairo University Completed No outcome recorded
Phase 11 trial
Phase 1 NCT03755037 Comparator Jan 2017 → Apr 2018 female infertility Nesreen Abdel Fattah Abdullah Shehata Completed No outcome recorded
Phase 1/22 trials
Phase 1/2 NCT04916925 Background Aug → Sep 2021 letrozole toxicity, polycystic ovary syndrome, vitamin D deficiency Ain Shams University Unknown No outcome recorded
Phase 1/2 NCT00947713 Comparator Aug 2009 → Aug 2010 gonadal disorder Royan Institute Completed No outcome recorded
Phase 214 trials
Phase 2 NCT05231980 Background Jun 2022 → May 2023 polycystic ovary syndrome Ain Shams University Completed No outcome recorded
Phase 2 NCT03245827 Comparator Apr 2019 → Oct 2021 hypogonadotropic hypogonadism Sandeep Singh Dhindsa, M.D., F.A.C.E Terminated No outcome recorded
Phase 2 NCT03674385 Background Jul 2018 → Mar 2019 polycystic ovary syndrome Ain Shams University Completed No outcome recorded
Phase 2 NCT02656121 Background Feb 2016 → Nov 2018 polycystic ovary syndrome Ain Shams University Completed No outcome recorded
Phase 2 NCT02663830 Comparator Jan 2016 → Jan 2017 anovulation Ain Shams University Completed No outcome recorded
Phase 2/37 trials
Phase 2/3 NCT05846906 Background Oct 2021 → Apr 2022 female infertility Beni-Suef University Completed No outcome recorded
Phase 2/3 NCT04870502 Comparator Apr 2019 → Jul 2020 polycystic ovary syndrome Saudi German Hospital - Madinah Completed No outcome recorded
Phase 2/3 NCT05702957 Comparator Sep 2016 → Oct 2019 female infertility, polycystic ovary syndrome Services Institute of Medical Sciences, Pakistan Completed No outcome recorded
Phase 2/3 NCT02775734 Comparator May 2016 → Mar 2017 polycystic ovary syndrome Ain Shams University Completed No outcome recorded
Phase 2/3 NCT02237755 Comparator Oct → Nov 2014 female infertility University of Athens Unknown No outcome recorded
Phase 310 trials
Phase 3 NCT03059173 Background Sep 2023 → Sep 2027 expected polycystic ovary syndrome University Hospital, Lille Recruiting No outcome recorded
Phase 3 NCT03396380 Comparator Jul 2017 → Mar 2018 female infertility Ain Shams University Unknown No outcome recorded
Phase 3 NCT03241472 Comparator Feb 2016 → May 2017 infertility disorder Assiut University Completed No outcome recorded
Phase 3 NCT02264847 Comparator Oct 2014 → Apr 2017 anovulation Cairo University Unknown No outcome recorded
Phase 3 NCT01638988 Comparator Sep → Nov 2013 diabetes mellitus, polycystic ovary syndrome Clinique Ovo Withdrawn No outcome recorded
Phase 427 trials
Phase 4 NCT07462065 Comparator Mar → Jun 2026 overdue female infertility PAEC General Hospital, Islamabad Recruiting No outcome recorded
Phase 4 NCT06178523 Comparator Jan → Dec 2024 infertility disorder Batterjee Medical College Completed No outcome recorded
Phase 4 NCT05753098 Background Jan 2021 → Jan 2023 female infertility Beni-Suef University Completed No outcome recorded
Phase 4 NCT04306692 Comparator Jul 2020 → Apr 2021 female infertility, polycystic ovary syndrome University Hospital, Ghent Terminated No outcome recorded
Phase 4 NCT04302532 Background Jul → Sep 2020 Karachi Medical and Dental College Completed No outcome recorded
Phase not applicable24 trials
NCT07568574 Background Mar 2026 → May 2028 expected Enhanced Emirates Limited Enrolling by invitation No outcome recorded
NCT06635538 Background Oct 2024 → Apr 2025 overdue female infertility Fundacion Dexeus Recruiting No outcome recorded
NCT06507332 Comparator Mar → Sep 2024 polycystic ovary syndrome Egymedicalpedia Unknown No outcome recorded
NCT05670795 Comparator Jan 2023 → May 2024 infertility disorder Bezmialem Vakif University Unknown No outcome recorded
NCT07398924 Background Jan 2022 → Jun 2023 anovulation, female infertility Yuzuncu Yil University Completed No outcome recorded

Evidence & citations 26 cited values

Every value below carries the sentence it was read from. 158 sources stand behind the page.

FieldValueCited text
Known as clomiphene “100 mg clomiphene Citrate (Clomid , global Napi , Egypt) CC tablets taken from day 3 to day 7 of the cycle” NCT02562664
31

“Drug: ClomipheneNCT01679574

NCT00068861

NCT07568574

NCT00795808

NCT02274311

NCT01904734

NCT02294773

NCT04170439

NCT03245827

NCT01289756

NCT02802865

NCT01607320

NCT02137265

NCT01953796

NCT01793038

NCT03400722

NCT00697814

NCT02775877

NCT02638285

NCT04010942

NCT02377479

NCT03989024

NCT03933618

NCT01155518

NCT03476356

NCT01921166

NCT02663830

NCT01291056

NCT02647424

NCT02690870

NCT04306692

Known as Chloramiphene ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051
Known as Clomid “All patients received 100 mg CC (Clomid®; Global Napi Pharmaceuticals, Cairo, Egypt) for 5 days starting from day 3 of spontaneous or induced menstruation.” NCT01157312
16

“induction of ovulation with clomiphene citrate (Clomid®, Aventis) 50 mg tablet twice daily starting from the third day of menstrual cycle and for 5 days” PMID 32363556 May 2020

Clomid 50 mg per day will be administered orally and human chorionic gonadotrophin ( choriomon ) 5000 IU will be administered IM once per week.” NCT01529177

“Thirty PCOS patients treated with 3 cycles of 100mg/day of Clomid (clomiphene citrate) on days 3 to 7 following an initial provera withdrawal” NCT01607320

“Clomiphene citrate(Clomid; Aventis pharma S.AE, Global Napi pharmaceuticals, Cairo, Egypt) 100 mg/day is administered from cycle day 3 to 7.” NCT01232075

“100 mg clomiphene Citrate (Clomid , global Napi , Egypt) CC tablets taken from day 3 to day 7 of the cycle” NCT02562664

“patients in either group received 100 mg CC (Clomid®; Global Napi Pharmaceuticals,Cairo, Egypt)” NCT01008046

“Clomiphene citrate 50 mg tab oral tablets(Clomid 50 mg tablets Global Napi , Egypt)” NCT01212263

“Clomiphene citrate (Clomid) is often used for assisted reproductive technologies” NCT06701071

Clomid is the standard first drug of treatment for ovulation induction” NCT01793038

“Clomiphene citrate (clomid) (50mg) will be given for 5 days” NCT03178500

“oral Clomiphene Citrate (Clomid®) 150 mg/day for 5 days” NCT04157725

“clomiphene citrate (clomid 50mg ®, Sanofi aventis)” NCT03301233

NCT03755037

NCT04916925

NCT04619914

NCT03028532

Known as Clomifene ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051
Known as Clomifene Citrate clomifene citrate 50 mg three times daily” NCT04052607
5

NCT03615547

NCT01791751

NCT02544776

NCT01389713

NCT00478504

Known as Clomifeni citras ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051
Known as Clomifeno ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051
Known as clomiphen citrate “100mg of clomiphencitrate(Serophene®) are added to a high dose of HMG (450 IU of Merional®) in the early follicular phase of the stimulation (day 3 to 7).” NCT01577472
1

“Initial clomiphen citrate (CC) doses were 50 mg daily for 5 days starting on cycle day 3.” NCT02269306

Known as Clomiphene Citrate “OBJECTIVE: To evaluate pregnancy rates with letrozole and clomiphene citrate (CC) alone for superovulation in an intrauterine insemination program for women with recently...” PMID 22181973 Jan 2012
122

Clomiphene citrate (Ovumid®, Iran Hormones Company) 25 mg/day with co-treatment of Letrozole (Letrofem®, Iran Hormones Company) 2.5 mg/day are given from cycle day 3 onwards.” NCT02732808

“Randomised controlled trial on the effect of clomiphene citrate and gonadotropin dose on ovarian response markers and IVF outcomes in poor responders.” PMID 33367742 Mar 2021

“Following ovulation or no response to increasing clomiphene-citrate doses, correlations between predictors and treatment responses were analyzed.” PMID 26848057 Dec 2015

“Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With HMG in PCOs Patients With Previous Clomiphene Citrate (CC)-Resistant Anovulation” NCT00947713

“Letrozole Versus Combined Metformin and Clomiphene Citrate for Ovulation Induction in Clomiphene-Resistant Women With Polycystic Ovary Syndrome” NCT00911313

“Thirty PCOS patients treated with 3 cycles of 100mg/day of Clomid (clomiphene citrate) on days 3 to 7 following an initial provera withdrawal” NCT01607320

“Combined Metformin and Clomiphene Citrate (CC) or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome (PCOS)” NCT00969631

Clomiphene citrate, a selective estrogen-receptor modulator that antagonizes the negative feedback of estrogen at the hypothalamus” NCT04361175

Clomiphene citrate is a well-established agent that has been empirically used in cases of idiopathic oligospermia.” PMID 16291975 Nov 2005

Clomiphene citrate (CC) is a commonly prescribed pharmacologic agent used to induce ovulation in women with PCOS.” NCT06507332

Clomiphene citrate 100mg (2 tablets clomid 50mg each per day,from 2nd to 6th day of the cycle ) will be added” NCT04010942

“100 mg clomiphene Citrate (Clomid , global Napi , Egypt) CC tablets taken from day 3 to day 7 of the cycle” NCT02562664

Clomiphene citrate, a SERM that increases luteinizing hormone and follicle stimulating hormone secretion” NCT02274311

clomiphene citrate 50 mg tablets twice /day for 5 days plus 37.5 IU uFSH IM injections daily for 10 days” NCT01793038

“CLOMID (clomiphene citrate tablets USP) is an orally administered, nonsteroidal, ovulatory stimulant” NCT04619914

“Each tablet contains 50 mg of clomiphene citrate which means 33,9 mg of clomiphene.” NCT04306692

Clomiphene citrate 50 mg tab oral tablets(Clomid 50 mg tablets Global Napi , Egypt)” NCT01212263

Clomiphene citrate is a well known selective estrogen receptor modulator” NCT00697814

“Oral clomiphene citrate: 100 mg/day until the day of the triggering.” NCT02448459

“Oral clomiphene citrate: 100 mg/day until the day of the triggering.” NCT02288143

“N-acetyl cysteine and clomiphene citrate(CC)with combined metformin” NCT01008046

“patients received a 50-mg dose of clomiphene citrate.” PMID 26848057 Dec 2015

clomiphene citrate (clomid 50mg ®, Sanofi aventis)” NCT03301233

Clomiphene Citrate for induction of ovulation” NCT02656121

“Experimental: Clomiphene Citrate (CC) + rFSH” NCT04983173

“Drug: Clomiphene citrateNCT01638988

Clomiphene Citrate 25mg” NCT03933618

NCT04331197

NCT00835744

NCT01213147

NCT01004068

NCT05089344

NCT00413179

NCT03316469

NCT02380755

NCT00501839

NCT03566225

NCT00461643

NCT02479256

NCT03178500

NCT01008319

NCT04157725

NCT02330757

NCT01910766

NCT02575248

NCT01909141

NCT06178523

NCT03630341

NCT03681197

NCT03674385

NCT06564961

NCT02381184

NCT02523898

NCT05206448

NCT05096169

NCT00610077

NCT02186782

NCT00213148

NCT02865681

NCT03059173

NCT02890238

NCT05702957

NCT02551367

NCT02264847

NCT03309436

NCT03241472

NCT02024984

NCT01157312

NCT02255578

NCT06813118

NCT00471523

NCT04302532

NCT02520505

NCT01638988

NCT00830492

NCT01044862

NCT02644304

NCT00449514

NCT02344888

NCT07616973

NCT07398924

NCT07523022

NCT01880086

NCT02710981

NCT00502229

NCT05846906

NCT00296465

NCT01718444

NCT03549741

NCT02352597

NCT03396380

NCT00719186

NCT02775734

NCT03770026

NCT01232075

NCT07462065

NCT00427700

NCT05670795

NCT03806036

NCT00005104

NCT00796289

NCT02201914

NCT02436226

NCT06701071

NCT00844350

NCT01529177

NCT06635538

NCT04870502

NCT04210765

NCT04177693

NCT03398993

NCT05106712

NCT05231980

NCT01219101

NCT00005654

NCT04944836

NCT03709849

NCT02237755

NCT05753098

NCT00558077

NCT02345837

NCT01340521

Known as Clomiphene citrate (1:1) ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051
Known as Clophene ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051
Known as Clostilbegyt ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051
Known as Ikaclomine ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051
Known as MER-41 ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051
Known as Milophene ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051
Known as MRL-41 ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051
Known as NSC-35770 ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051
Known as Omifin “CC 50 mg/day (Omifin®) + rFSH 150 IU (Ovaleap®)” NCT04983173
Known as Ovumid “Clomiphene citrate (Ovumid®, Iran Hormones Company) 25 mg/day with co-treatment of Letrozole (Letrofem®, Iran Hormones Company) 2.5 mg/day are given from cycle day 3 onwards.” NCT02732808
Known as Pergotime ChEMBL registry synonym — accepted as the source's own label CHEMBL2355051
Known as Serophene “100mg of clomiphencitrate(Serophene®) are added to a high dose of HMG (450 IU of Merional®) in the early follicular phase of the stimulation (day 3 to 7).” NCT01577472
Known as Tecnovula “clomiphene citrate 50 mg (Tecnovula®)” NCT05753098
Action Activate “Traditionally, clomiphene citrate, an estrogen receptor agonist, is the most used drug for this type of anovulation.” NCT00427700
Modality Other / unclassified “Clomiphene citrate, a selective estrogen receptor modulator (SERM) oral medication which inhibits estrogen effects (feedback) on the brain” NCT01880086
Route Oral oral clomiphene citrate daily” NCT00005104